ESOGER: Evolution and Adaptation to Caregiver of a Socio-geriatric Evaluation

Sponsor
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal (Other)
Overall Status
Recruiting
CT.gov ID
NCT05062590
Collaborator
(none)
260
1
2
22.9
11.4

Study Details

Study Description

Brief Summary

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 à 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) conclude that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital plateform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. Investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. For this study, the investigator aims to evaluate the effect of ESOGER on EP physical and mental health, loss of autonomy, social isolation, quality of life and ressources consumption.

Condition or Disease Intervention/Treatment Phase
  • Other: Recommendations
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
260 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Other
Official Title:
Socio-geriatric Evaluation (ESOGER): A Clinical Tool in Telehealth to Fight Against Vulnerable Seniors's Health Alterations and Social Isolation
Actual Study Start Date :
Apr 4, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group Intervention

Experimental: Group 1 The intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.

Other: Recommendations
Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP

No Intervention: Group control

The participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations

Outcome Measures

Primary Outcome Measures

  1. COVID-19 symptoms [3 months]

    presence or not of fever, cough, and shortness of breath (binary question)

  2. psychological fraility [3 months]

    Anxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious

  3. Social health [3 months]

    Issues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)

  4. Socio-economic characteristics [3 months]

    Presence or not of socio-economic problems (binary questions)

  5. Participant's Quality of life [3 months]

    Measured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.

  6. Autonomy [3 months]

    ADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.

Secondary Outcome Measures

  1. Caregiver burden [3 months]

    Based on Zarit scale, score from 0= no burden to 16= high caregiver burnder

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 65 and more

  • Living at home on the territory CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL) of Jeanne-Mance

  • Brief Geriatric Assessment (BGA) score of 1/14 or more defining a severly to milidly frail health.

Exclusion Criteria:
  • Principal address outside of the CCSMTL's Jeanne-Mance territory

  • Participate at another clinical trial, to avoid interferences

  • Not understand written or spoken French or English, questionnaires are only available in French and English.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CRIUGM Montréal Quebec Canada H3W 1W5

Sponsors and Collaborators

  • Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Olivier Beauchet, MD, PhD, Senior researcher, Director of laboratory, Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
ClinicalTrials.gov Identifier:
NCT05062590
Other Study ID Numbers:
  • 2022-616
First Posted:
Sep 30, 2021
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 20, 2022